Company Filing History:
Years Active: 2021
Title: **Innovative Contributions of Dana J Levine in Metal-olsalazine Coordination Polymers**
Introduction
Dana J Levine, based in Bonita, California, is an accomplished inventor recognized for her innovative work in the field of coordination polymers for medical applications. With a focus on enhancing therapeutic delivery systems, her research contributes significantly to the intersection of chemistry and medicine.
Latest Patents
Dana J Levine holds one notable patent: "Metal-olsalazine coordination polymers for medical applications." This patent describes the synthesis of a suite of M(Holz) and M(olz) materials, where M represents various dications such as Magnesium (Mg), Calcium (Ca), Strontium (Sr), Iron (Fe), Cobalt (Co), Nickel (Ni), Copper (Cu), and Zinc (Zn). The innovative family of metal olsalazine coordination polymers and metal-organic frameworks provides unique structures that resist degradation in acidic environments while preferentially releasing olsalazine at neutral pH levels. These mesoporous frameworks feature high surface areas with hexagonal pore apertures, approximately 27 Å in diameter, and possess coordinatively unsaturated metal sites, allowing for the direct grafting of biologically active molecules.
Career Highlights
As a member of the University of California, Dana has played a pivotal role in advancing research in materials science and drug delivery. Her work emphasizes the potential of using multiple therapeutic components delivered at different rates, showcasing her commitment to innovative healthcare solutions.
Collaborations
Dana collaborates with esteemed colleagues, including Jeffrey R Long and Miguel I Gonzalez. Together, they contribute to research efforts that aim to push the boundaries of existing medical treatments through innovative material design and application.
Conclusion
Dana J Levine’s contributions to the field of metal-olsalazine coordination polymers underscore her role as a significant inventor in advancing medical applications. Her patent exemplifies how innovative materials can create new possibilities in therapeutic delivery systems, benefiting both research institutions and the healthcare industry.